BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+11.62%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+16%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
6.71%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
149
New
25
Increased
54
Reduced
51
Closed
11
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$12.2M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.1M |
| 3 |
Cigna
CI
|
$11.7M |
| 4 |
Viatris
VTRS
|
$9.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$8.05M |
Top Sells
| 1 |
Incyte
INCY
|
$11.8M |
| 2 |
UnitedHealth
UNH
|
$11.3M |
| 3 |
Align Technology
ALGN
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.27M |
| 5 |
Integra LifeSciences
IART
|
$8.56M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Industrials | 0.76% |
| 3 | Technology | 0.15% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Vertex Pharmaceuticals
VRTX
$102B
| $7.19M | 0.61% |
42,294
-54,516
| -56% | -$9.27M |
|
52
Thermo Fisher Scientific
TMO
$183B
| $6.03M | 0.51% |
29,131
+5,283
| +22% | +$1.09M |
|
53
Regeneron Pharmaceuticals
REGN
$59.8B
| $5.96M | 0.51% |
17,260
-10,120
| -37% | -$3.49M |
|
|
WCG
54
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.43M | 0.46% |
+22,050
| New | +$5.43M |
|
55
Molina Healthcare
MOH
$9.6B
| $5.12M | 0.44% |
52,240
+8,740
| +20% | +$856K |
|
56
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.67M | 0.4% |
49,519
+5,169
| +12% | +$487K |
|
57
Cooper Companies
COO
$13.3B
| $4.54M | 0.39% |
77,200
-12,000
| -13% | -$706K |
|
|
TRHC
58
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.3M | 0.37% |
67,306
+9,306
| +16% | +$594K |
|
59
Neurocrine Biosciences
NBIX
$13.5B
| $4.28M | 0.36% |
43,550
-10,100
| -19% | -$992K |
|
60
Teleflex
TFX
$5.57B
| $3.76M | 0.32% |
14,000
| – | – |
|
|
61
Integra LifeSciences
IART
$1.18B
| $3.75M | 0.32% |
58,161
-132,839
| -70% | -$8.56M |
|
62
Globus Medical
GMED
$7.94B
| $3.74M | 0.32% |
74,045
+25,195
| +52% | +$1.27M |
|
63
Henry Schein
HSIC
$8.14B
| $3.73M | 0.32% |
65,494
+10,669
| +19% | +$608K |
|
64
iRhythm Technologies
IRTC
$5.67B
| $3.73M | 0.32% |
45,921
+12,521
| +37% | +$1.02M |
|
|
65
Incyte
INCY
$17B
| $3.68M | 0.31% |
54,850
-175,776
| -76% | -$11.8M |
|
|
CERN
66
DELISTED
Cerner Corp
CERN
| $3.46M | 0.3% |
57,900
-6,100
| -10% | -$365K |
|
|
ESRX
67
DELISTED
Express Scripts Holding Company
ESRX
| $3.44M | 0.29% |
44,500
-5,000
| -10% | -$386K |
|
68
Omnicell
OMCL
$1.51B
| $3.35M | 0.29% |
63,945
+43,945
| +220% | +$2.3M |
|
|
XENT
69
DELISTED
Intersect ENT, Inc
XENT
| $3.3M | 0.28% |
88,028
+49,598
| +129% | +$1.86M |
|
70
Dentsply Sirona
XRAY
$2.77B
| $3.29M | 0.28% |
75,093
+20,593
| +38% | +$901K |
|
|
SGEN
71
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.29M | 0.28% |
49,500
+650
| +1% | +$43.1K |
|
|
HZNP
72
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.17M | 0.27% |
+191,578
| New | +$3.17M |
|
|
HMSY
73
DELISTED
HMS Holdings Corp.
HMSY
| $3.16M | 0.27% |
146,069
+92,569
| +173% | +$2M |
|
74
Bausch Health
BHC
$2.72B
| $3.02M | 0.26% |
130,000
+30,000
| +30% | +$697K |
|
75
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.01M | 0.26% |
39,150
-1,150
| -3% | -$88.4K |
|